Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells

Biology of the Cell

Volumn 101, Issue 9, 2009, Pages 525-539

  Sulpice, Eric ^a   Ding, Shunli ^a,c   Muscatelli Groux, Béatrice ^a   Bergé, Mathieu ^a   Han, Zhong Chao ^b   Plouet, Jean ^a   Tobelem, Gérard ^a   Merkulova Rainon, Tatyana ^a  

^a Université René Diderot   (France)

^b INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Angiogenesis; Endothelial cell; Hepatocyte growth factor (HGF); Signal transduction; Vascular endothelial growth factor (VEGF)

Indexed keywords

FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; RAC PROTEIN; RHO FACTOR; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN A 165; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CHEMOTAXIS; CONTROLLED STUDY; CYTOSKELETON; DOWNSTREAM PROCESSING; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME KINETICS; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SPACE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; CELL CULTURE; GENETICS; METABOLISM;

CELLS, CULTURED; ENDOTHELIAL CELLS; HEPATOCYTE GROWTH FACTOR; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 70149095573     PISSN: 02484900     EISSN: 1768322X     Source Type: Journal    
DOI: 10.1042/BC20080221     Document Type: Article

References (44)

1. Autiero, M., Waltenberger, J., Communi, D., Kranz, A., Moons, L., Lambrechts, D., Kroll, J., Plaisance, S., De Mol, M., Bono, F. et al. (2003) Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat. Med. 9, 936-943
2. Birchmeier, C., Birchmeier, W., Gherardi, E. and Vande Woude, G. F. (2003) Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915-925
3. Birukova, A.A., Cokic, I., Moldobaeva, N. and Birukov, K.G. (2009) Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF. Am. J. Respir. Cell Mol. Biol. 40, 99-107
4. Carmeliet, P. (2000) VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat. Med. 6, 1102-1103
5. Carmeliet, P. and Jain, R.K. (2000) Angiogenesis in cancer and other diseases. Nature 407, 249-257
6. Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H. et al. (2001) Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7, 575-583
7. Cines, D.B., Pollak, E.S., Buck, C.A., Loscalzo, J., Zimmerman, G.A., McEver, R.P., Pober, J.S., Wick, T.M., Konkle, B.A., Schwartz, B.S. et al. (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91, 3527-3561
8. Conway, E.M., Collen, D. and Carmeliet, P. (2001) Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 49, 507-521
9. Ding, S., Merkulova-Rainon, T., Han, Z.C. and Tobelem, G. (2003) HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. Blood 101, 4816-4822
10. Duval, M., Bedard-Goulet, S., Delisle, C. and Gratton, J.P. (2003) Vascular endothelial growth factor-dependent down-regulation of Flk-1/ KDR involves Cbl-mediated ubiquitination. Consequences on nitric oxide production from endothelial cells. J. Biol. Chem. 278, 20091-20097
11. Ferrara, N., Gerber, H.P. and LeCouter, J. (2003) The biology of VEGF and its receptors. Nat. Med. 9, 669-676
12. Gao, Y., Dickerson, J.B., Guo, F., Zheng, J. and Zheng, Y. (2004) Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl. Acad. Sci. U.S.A. 101, 7618-7623
13. Garrido, C., Schmitt, E., Cande, C., Vahsen, N., Parcellier, A. and Kroemer, G. (2003) HSP27 and HSP70: potentially oncogenic apoptosis inhibitors. Cell Cycle 2, 579-584
14. Gerritsen, M.E., Tomlinson, J.E., Zlot, C., Ziman, M. and Hwang, S. (2003) Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells. Br. J. Pharmacol. 140, 595-610
15. Hammond, D.E., Carter, S. and Clague, M.J. (2004) Met receptor dynamics and signalling. Curr. Top. Microbiol. Immunol. 286, 21-44
16. Hoang, M.V., Whelan, M.C. and Senger, D.R. (2004) Rho activity critically and selectively regulates endothelial cell organization during angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 101, 1874-1879
17. Ishizaki, T., Uehata, M., Tamechika, I., Keel, J., Nonomura, K., Maekawa, M. and Narumiya, S. (2000) Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol. Pharmacol. 57, 976-983
18. Jaffe, A.B. and Hall, A. (2005) Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21, 247-269
19. Lee, S., Jilani, S.M., Nikolova, G.V., Carpizo, D. and Iruela-Arispe, M.L. (2005) Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169, 681-691
20. Liu, F., Schaphorst, K.L., Verin, A.D., Jacobs, K., Birukova, A., Day, R.M., Bogatcheva, N., Bottaro, D.P. and Garcia, J.G. (2002) Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3β. FASEB J. 16, 950-962
21. Lubarsky, B. and Krasnow, M.A. (2003) Tube morphogenesis: making and shaping biological tubes. Cell 112, 19-28
22. Murdaca, J., Treins, C., Monthouel-Kartmann, M.N., Pontier-Bres, R., Kumar, S., Van, O.E. and Giorgetti-Peraldi, S. (2004) Grb10 prevents Nedd4-mediated vascular endothelial growth factor receptor-2 degradation. J. Biol. Chem. 279, 26754-26761
23. Nagy, J.A. and Senger, D.R. (2006) VEGF-A, cytoskeletal dynamics, and the pathological vascular phenotype. Exp. Cell Res. 312, 538-548
24. Nobes, C.D. and Hall, A. (1995) Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81, 53-62
25. Nobes, C.D. and Hall, A. (1999) Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 144, 1235-1244
26. Pankov, R., Endo, Y., Even-Ram, S., Araki, M., Clark, K., Cukierman, E., Matsumoto, K. and Yamada, K.M. (2005) A Rac switch regulates random versus directionally persistent cell migration. J. Cell Biol. 170, 793-802
27. Park, J.E., Chen, H.H., Winer, J., Houck, K.A. and Ferrara, N. (1994) Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, invitro and invivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 269, 25646-25654
28. Pertz, O. and Hahn, K.M. (2004) Designing biosensors for Rho family proteins - deciphering the dynamics of Rho family GTPase activation in living cells. J. Cell Sci. 117, 1313-1318
29. Rosario, M. and Birchmeier, W. (2003) How to make tubes: signaling by the Met receptor tyrosine kinase. Trends Cell Biol. 13, 328-335
30. Schlaepfer, D.D., Mitra, S.K. and Ilic, D. (2004) Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim. Biophys. Acta 1692, 77-102
31. Silvagno, F., Follenzi, A., Arese, M., Prat, M., Giraudo, E., Gaudino, G., Camussi, G., Comoglio, P.M. and Bussolino, F. (1995) Invivo activation of met tyrosine kinase by heterodimeric hepatocyte growth factor molecule promotes angiogenesis. Arterioscler. Thromb. Vasc. Biol. 15, 1857-1865
32. Simons, M. and Ware, J.A. (2003) Therapeutic angiogenesis in cardiovascular disease. Nat. Rev. Drug Discov. 2, 863-871
33. Singleton, P.A., Salgia, R., Moreno-Vinasco, L., Moitra, J., Sammani, S., Mirzapoiazova, T. and Garcia, J.G. (2007) CD44 regulates hepatocyte growth factor-mediated vascular integrity: Role of c-Met, Tiam1/Rac1, dynamin 2 and cortactin. J. Biol. Chem. 282, 30643-30657
34. Sulpice, E., Plouet, J., Berge, M., Allanic, D., Tobelem, G. and Merkulova-Rainon, T. (2008) Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity. Blood 111, 2036-2045
35. Tallarida, R.J. (2000) Drug Synergism and Dose-Effect Data Analysis, Chapman & Hall/CRC, Boca Raton
36. Tammela, T., Enholm, B., Alitalo, K. and Paavonen, K. (2005) The biology of vascular endothelial growth factors. Cardiovasc. Res. 65, 550-563
37. Trusolino, L. and Comoglio, P.M. (2002) Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat. Rev. Cancer 2, 289-300
38. Van Belle, E., Witzenbichler, B., Chen, D., Silver, M., Chang, L., Schwall, R. and Isner, J.M. (1998) Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 97, 381-390
39. van Nieuw Amerongen, G.P., Koolwijk, P., Versteilen, A. and van Hinsbergh, V. (2003) Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis invitro. Arterioscler. Thromb. Vasc. Biol. 23, 211-217
40. Weis, S.M. and Cheresh, D.A. (2005) Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437, 497-504
41. 121. J. Biol. Chem. 276, 25520-25531
42. Wojciak-Stothard, B. and Ridley, A.J. (2002) Rho GTPases and the regulation of endothelial permeability. Vascul. Pharmacol. 39, 187-199
43. Wojta, J., Kaun, C., Breuss, J.M., Koshelnick, Y., Beckmann, R., Hattey, E., Mildner, M., Weninger, W., Nakamura, T., Tschachler, E. and Binder, B.R. (1999) Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. Lab. Invest. 79, 427-438
44. Xin, X., Yang, S., Ingle, G., Zlot, C., Rangell, L., Kowalski, J., Schwall, R., Ferrara, N. and Gerritsen, M.E. (2001) Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis invitro and invivo. Am. J. Pathol. 158, 1111-1120